Jurors have completed a third day of deliberations at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).
They got the case Monday in New York. After deliberating Wednesday they went home without a verdict. Deliberations will resume Thursday.
Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.
The former biotech CEO nicknamed "Pharma Bro" is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.
If convicted of the most serious charges, he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.